Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
07 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/07/3022822/0/en/Shareholder-Group-Led-by-Founder-Mina-Sooch-Nominates-Majority-Slate-of-Director-Candidates-to-the-Board-of-Opus-Genetics-Inc.html
12 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/12/2979129/0/en/Opus-Genetics-Announces-Financial-Results-for-Third-Quarter-2024-and-Provides-Corporate-Update.html
23 Oct 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/ocuphire-transform-gene-therapy-focused-biotech-opus-acquisition
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2967317/0/en/Ocuphire-Pharma-Announces-Acquisition-of-Opus-Genetics.html
30 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/09/30/2955118/0/en/Ocuphire-Pharma-Announces-Publication-of-Full-Phase-3-Results-of-Phentolamine-Ophthalmic-Solution-0-75-for-Pharmacologically-Induced-Mydriasis-in-Ophthalmology.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/06/2941917/0/en/UPDATE-Ocuphire-Pharma-Initiates-VEGA-3-Phase-3-Trial-Evaluating-Phentolamine-Ophthalmic-Solution-0-75-for-Presbyopia.html
ABOUT THIS PAGE